| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |